Professor | Changwu Xu | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Changwu Xu
Contact Information	xuchangwu@whu.edu.cn
Language ability	English, Chinese
Province	Hubei

Upload Avatar (500 x 500)

Name

Changwu Xu

Contact Information

xuchangwu@whu.edu.cn

Language ability

English, Chinese

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	2004.9-2009.6 Bachelor of Clinical Medicine: Wuhan University 2009.9-2014.6 Master and PhD in Internal Medicine: Wuhan University 2012.10-2013.12 Joint Training in the USA: University of Chicago
Work Experience	2014.07-2014.11 Resident in Cardiovascular Medicine, Renmin Hospital of Wuhan University 2014.12-2019.11 Attending Physician in Cardiovascular Medicine, Renmin Hospital of Wuhan University 2019.12-present Associate Chief Physician in Cardiovascular Medicine, Renmin Hospital of Wuhan University
Awards	2019: First Prize in Medical Science Progress by Huaxia Medical Science

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

2004.9-2009.6 Bachelor of Clinical Medicine: Wuhan University
2009.9-2014.6 Master and PhD in Internal Medicine: Wuhan University
2012.10-2013.12 Joint Training in the USA: University of Chicago

Work Experience

2014.07-2014.11 Resident in Cardiovascular Medicine, Renmin Hospital of Wuhan University
2014.12-2019.11 Attending Physician in Cardiovascular Medicine, Renmin Hospital of Wuhan University
2019.12-present Associate Chief Physician in Cardiovascular Medicine, Renmin Hospital of Wuhan University

Awards

2019: First Prize in Medical Science Progress by Huaxia Medical Science

Areas of Focus	Vascular Injury, Aging and Repair Myocardial Ischemia Reperfusion Injury Translational and Clinical Research of Coronary Heart Disease
Publications	Downregulation of P300/CBP-Associated Factor Protects from Vascular Aging via Nrf2 Signal Pathway Activation, Qiu L, Liu X, Xia H, Xu C, 2022 Galangin inhibits neointima formation induced by vascular injury via regulating the PI3K/AKT/mTOR pathway, Wu B, Xu C, Ding HS, Qiu L, Gao JX, Li M, Xiong Y, Xia H, Liu X, 2022 Downregulation of p300/CBP-associated factor inhibits cardiomyocyte apoptosis via suppression of NF-κB pathway in ischaemia/reperfusion injury rats, Qiu L, Liu X, Li W, Liu Z, Xu C, Xia H, 2021 Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention, He W, Xu C, Wang X et al., 2021 Metformin decreased myocardial fibrosis and apoptosis in hyperhomocysteinemia -induced cardiac hypertrophy, Zhao Q, Song W, Huang J, Wang D, Xu C, 2021 Downregulation of P300/CBP-Associated Factor Attenuates Myocardial Ischemia-Reperfusion Injury Via Inhibiting Autophagy, Qiu L, Xu C, Xia H, Chen J, Liu H, Jiang H, 2020 Downregulation of the transcriptional co-activator PCAF inhibits the proliferation and migration of vascular smooth muscle cells and attenuates NF-κB-mediated inflammatory responses, Qiu L, Xu C, Chen J, Li Q, Jiang H, 2019 Cantharidin Attenuates the Proliferation and Migration of Vascular Smooth Muscle Cells through Suppressing Inflammatory Response, Qiu L, Xu C, Jiang H, Li W, Tong S, Xia H, 2019

Areas of Focus

Vascular Injury, Aging and Repair
Myocardial Ischemia Reperfusion Injury
Translational and Clinical Research of Coronary Heart Disease

Publications

Downregulation of P300/CBP-Associated Factor Protects from Vascular Aging via Nrf2 Signal Pathway Activation, Qiu L, Liu X, Xia H, Xu C, 2022
Galangin inhibits neointima formation induced by vascular injury via regulating the PI3K/AKT/mTOR pathway, Wu B, Xu C, Ding HS, Qiu L, Gao JX, Li M, Xiong Y, Xia H, Liu X, 2022
Downregulation of p300/CBP-associated factor inhibits cardiomyocyte apoptosis via suppression of NF-κB pathway in ischaemia/reperfusion injury rats, Qiu L, Liu X, Li W, Liu Z, Xu C, Xia H, 2021
Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention, He W, Xu C, Wang X et al., 2021
Metformin decreased myocardial fibrosis and apoptosis in hyperhomocysteinemia -induced cardiac hypertrophy, Zhao Q, Song W, Huang J, Wang D, Xu C, 2021
Downregulation of P300/CBP-Associated Factor Attenuates Myocardial Ischemia-Reperfusion Injury Via Inhibiting Autophagy, Qiu L, Xu C, Xia H, Chen J, Liu H, Jiang H, 2020
Downregulation of the transcriptional co-activator PCAF inhibits the proliferation and migration of vascular smooth muscle cells and attenuates NF-κB-mediated inflammatory responses, Qiu L, Xu C, Chen J, Li Q, Jiang H, 2019
Cantharidin Attenuates the Proliferation and Migration of Vascular Smooth Muscle Cells through Suppressing Inflammatory Response, Qiu L, Xu C, Jiang H, Li W, Tong S, Xia H, 2019

Vascular Injury Vascular Repair Aging Myocardial Ischemia Reperfusion Injury Coronary Heart Disease Translational Research Clinical Research Cardiovascular Disease Interventional Treatment

Jing Xiong - Wuhan University

Wu Dongfang - Wuhan University

Hao Xia - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us